Type 1 and type 2 diabetes are different, but the association between serum MBL levels and diabetic nephropathy is consistent with previous studies suggesting that diabetic microvascular lesions may have a similar pathogenesis, regardless of type 1 diabetes or type 2 diabetes. This evidence concerns the gene MBL2 and type 1 diabetes mellitus.